Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction

Abstract We construct a polygenic health index as a weighted sum of polygenic risk scores for 20 major disease conditions, including, e.g., coronary artery disease, type 1 and 2 diabetes, schizophrenia, etc. Individual weights are determined by population-level estimates of impact on life expectancy...

Full description

Bibliographic Details
Main Authors: Erik Widen, Louis Lello, Timothy G. Raben, Laurent C. A. M. Tellier, Stephen D. H. Hsu
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-22637-8
_version_ 1811335368993144832
author Erik Widen
Louis Lello
Timothy G. Raben
Laurent C. A. M. Tellier
Stephen D. H. Hsu
author_facet Erik Widen
Louis Lello
Timothy G. Raben
Laurent C. A. M. Tellier
Stephen D. H. Hsu
author_sort Erik Widen
collection DOAJ
description Abstract We construct a polygenic health index as a weighted sum of polygenic risk scores for 20 major disease conditions, including, e.g., coronary artery disease, type 1 and 2 diabetes, schizophrenia, etc. Individual weights are determined by population-level estimates of impact on life expectancy. We validate this index in odds ratios and selection experiments using unrelated individuals and siblings (pairs and trios) from the UK Biobank. Individuals with higher index scores have decreased disease risk across almost all 20 diseases (no significant risk increases), and longer calculated life expectancy. When estimated Disability Adjusted Life Years (DALYs) are used as the performance metric, the gain from selection among ten individuals (highest index score vs average) is found to be roughly 4 DALYs. We find no statistical evidence for antagonistic trade-offs in risk reduction across these diseases. Correlations between genetic disease risks are found to be mostly positive and generally mild. These results have important implications for public health and also for fundamental issues such as pleiotropy and genetic architecture of human disease conditions.
first_indexed 2024-04-13T17:23:06Z
format Article
id doaj.art-5816da80f15549efb8dc47ae9549ba2b
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-13T17:23:06Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5816da80f15549efb8dc47ae9549ba2b2022-12-22T02:37:53ZengNature PortfolioScientific Reports2045-23222022-10-0112111310.1038/s41598-022-22637-8Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk ReductionErik Widen0Louis Lello1Timothy G. Raben2Laurent C. A. M. Tellier3Stephen D. H. Hsu4Department of Physics and Astronomy, Michigan State UniversityDepartment of Physics and Astronomy, Michigan State UniversityDepartment of Physics and Astronomy, Michigan State UniversityDepartment of Physics and Astronomy, Michigan State UniversityDepartment of Physics and Astronomy, Michigan State UniversityAbstract We construct a polygenic health index as a weighted sum of polygenic risk scores for 20 major disease conditions, including, e.g., coronary artery disease, type 1 and 2 diabetes, schizophrenia, etc. Individual weights are determined by population-level estimates of impact on life expectancy. We validate this index in odds ratios and selection experiments using unrelated individuals and siblings (pairs and trios) from the UK Biobank. Individuals with higher index scores have decreased disease risk across almost all 20 diseases (no significant risk increases), and longer calculated life expectancy. When estimated Disability Adjusted Life Years (DALYs) are used as the performance metric, the gain from selection among ten individuals (highest index score vs average) is found to be roughly 4 DALYs. We find no statistical evidence for antagonistic trade-offs in risk reduction across these diseases. Correlations between genetic disease risks are found to be mostly positive and generally mild. These results have important implications for public health and also for fundamental issues such as pleiotropy and genetic architecture of human disease conditions.https://doi.org/10.1038/s41598-022-22637-8
spellingShingle Erik Widen
Louis Lello
Timothy G. Raben
Laurent C. A. M. Tellier
Stephen D. H. Hsu
Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction
Scientific Reports
title Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction
title_full Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction
title_fullStr Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction
title_full_unstemmed Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction
title_short Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction
title_sort polygenic health index general health and pleiotropy sibling analysis and disease risk reduction
url https://doi.org/10.1038/s41598-022-22637-8
work_keys_str_mv AT erikwiden polygenichealthindexgeneralhealthandpleiotropysiblinganalysisanddiseaseriskreduction
AT louislello polygenichealthindexgeneralhealthandpleiotropysiblinganalysisanddiseaseriskreduction
AT timothygraben polygenichealthindexgeneralhealthandpleiotropysiblinganalysisanddiseaseriskreduction
AT laurentcamtellier polygenichealthindexgeneralhealthandpleiotropysiblinganalysisanddiseaseriskreduction
AT stephendhhsu polygenichealthindexgeneralhealthandpleiotropysiblinganalysisanddiseaseriskreduction